Creative Touch Permanent Makeup and Aesthetics

Ceramide EOP (also known as Ceramide 9 or Cer[EOP]) is an omega-O-acylceramide that works alongside Ceramide EOS to form the long periodicity phase (LPP), a specific lamellar arrangement within the stratum corneum essential for water impermeability. Despite EOP and EOS together representing only around 10% of total stratum corneum ceramides, these acylceramides perform a structural anchoring function that no other ceramide subtype can replicate. This specificity explains why two products with comparable total ceramide content can perform very differently, and why barrier-repair formulations that specify individual ceramide types consistently outperform those that do not.

What makes Ceramide EOP structurally unusual is its ultralong N-acyl chain, typically 30–32 carbons long, with linoleic acid esterified at the omega position. This configuration allows EOP and EOS to anchor the lipid lamellae directly to the corneocyte envelope, the protein scaffold surrounding each stratum corneum cell. When this anchoring is intact, the lipid layers organise into a repeating lamellar structure that researchers measure as the LPP, characterised by an approximately 12–13 nm X-ray repeat spacing and closely associated with effective barrier function.

EOP differs from EOS in one structurally meaningful way: its phytosphingosine sphingoid base carries an additional hydroxyl group, making it more polar. Research using X-ray powder diffraction has shown that EOP can initiate LPP-like organisation even in a dry state, whereas EOS depends on hydration to form its hydrogen-bonding network. Together, these complementary properties create a more stable lamellar phase than either ceramide achieves independently, which is part of why their combined loss is characteristic of atopic and severely compromised skin.

EOP synthesis depends on a specific biochemical sequence: the fatty acid elongase ELOVL4 must first produce the ultralong-chain fatty acid substrate, which ceramide synthase CERS3 then incorporates into the final ceramide structure. Both enzymes are upregulated during keratinocyte differentiation and can be impaired by the same stressors that characterise compromised skin. Chronically elevated cortisol directly inhibits ceramide synthesis, measurably delaying barrier recovery. Inflammatory cytokines, particularly IL-4 and IL-13, suppress the barrier lipid synthesis pathways that include the acylceramide subtypes. During perimenopause and menopause, declining oestrogen reduces overall ceramide production, with structurally critical subtypes like EOP among the most vulnerable.

Clinical Implications for Barrier Repair

When evaluating ceramide products for barrier repair, formulation quality is particularly relevant for EOP and EOS. Research has shown that undissolved ceramide crystals in emulsions are significantly less effective than properly dispersed ceramides, and the acylceramides, with their ultralong chains, are especially prone to crystallisation in poorly engineered formulations. This is a practical reason why multi-ceramide products that specify individual types, including EOS and EOP, are worth seeking out rather than products that list ceramides without further detail.

Niacinamide supports endogenous ceramide synthesis broadly and may indirectly assist EOP production as part of its wider upregulation of barrier lipid pathways. At the professional treatment level, research on thulium fractional laser rejuvenation has found that early clinical responders demonstrate greater activation of lipid metabolism genes governing fatty acid and ceramide production, suggesting a pathway by which professional treatment can support the upstream biosynthetic machinery for EOP rather than simply improving surface hydration.

At Creative Touch, when clients present with reactive or chronically sensitised skin, we consider whether their product routine addresses the structural ceramide subtypes specifically. A formulation that lists ceramides without naming types often contains only Ceramide NP, which supports hydration but leaves the LPP-forming subtypes unaddressed. Multi-ceramide products that explicitly include EOS and EOP are our recommendation for clients in active repair phases, because restoring these specific subtypes is what allows the lipid architecture to stabilise from the inside out.